Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Sarcoma 1Gynecologic 1Genitourinary 1

Conditions

Thymoma 1Testicular Neoplasms 1Small Cell Lung Carcinoma 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Advanced Solid Tumors 1

Interventions

Filgrastim 4Carboplatin 4Peripheral Blood Stem Cell Transplantation 3Magnetic Resonance Spectroscopy 3Granulocyte Colony-Stimulating Factor 3Etoposide 3Busulfan 3aflibercept 2Trastuzumab 2Temozolomide 2Radiotherapy 2Polymerase Chain Reaction 2Melphalan 2Interleukin-12 Subunit p35 2Fluorodeoxyglucose F18 2Flow Cytometry 2FAPI-46 2Cyclophosphamide 2Bone Marrow Transplantation 2veliparib 1trioctyl phosphine oxide 1tipifarnib 1sodium thiosulfate 1sargramostim 1ixabepilone 1isophosphamide mustard 1guadecitabine 1fludarabine phosphate 1entinostat 1claudin 6 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Testicular Neoplasms × isophosphamide mustard × Clear all
NCT01242072 2012-07-18

Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies

Alaunos Therapeutics

Phase 1 Unknown
12 enrolled
GenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Ovarian Neoplasms, Osteosarcoma, Testicular Neoplasms, Thymoma, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡